Partners unveil cell culture product

Jan. 31, 2006 — SurModics Inc. (NASDAQ:SRDX), a provider of surface modification and drug delivery technologies to the healthcare industry, and Donaldson Co. (NYSE:DCI), a manufacturer of filtration systems, have introduced jointly developed extracellular matrix surfaces for cell culture as a research product.

The product line is the result of the relationship the two companies announced in May 2005. The companies combined Donaldson’s nanofiber technology and SurModics’ surface modification technology to create synthetic nanofibrillar cell culture products. The new products are meant to improve cell culture, cell-based bioassays and other in vitro cell-related applications.

POST A COMMENT

Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.